POINT Biopharma Global Inc.
PNTDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001811764
POINT Biopharma Global Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Dec 27, 2023; 126 institutions reported holding it in 13F filings for Q3 2023, worth $411.0M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding POINT Biopharma Global Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 68 | 84 | +16 |
| Shares | 39.9M | 48.5M | +8.61M (+21.6%) |
| Value | $318.0M | $330.5M | +$12.5M (+3.9%) |
New holders (33)
Institutions that held POINT Biopharma Global Inc. at the end of Q2 2022 but not at the end of Q1 2022.
Sold out (17)
Institutions that held POINT Biopharma Global Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Farallon Capital Management, L.L.C. | 626,322 | $4.99M |
| Millennium Management LLC | 588,075 | $4.69M |
| ExodusPoint Capital Management, LP | 240,515 | $1.92M |
| Silverarc Capital Management, LLC | 204,679 | $1.63M |
| Squarepoint Ops LLC | 108,792 | $867.0K |
| Jane Street Group, LLC | 47,366 | $378.0K |
| Bank of Montreal | 44,000 | $355.0K |
| D. E. Shaw & Co., Inc. | 43,744 | $349.0K |
| Marshall Wace, LLP | 38,110 | $304.0K |
| Balyasny Asset Management LLC | 35,565 | $283.0K |
| Sciencast Management LP | 32,368 | $256.0K |
| Mirabella Financial Services LLP | 25,963 | $207.0K |
| Y-Intercept (Hong Kong) Ltd | 17,568 | $140.0K |
| Shay Capital LLC | 15,000 | $120.0K |
| Diametric Capital, LP | 11,891 | $94.0K |
| Virtu Financial LLC | 11,594 | $92.0K |
| Ovata Capital Management Ltd | 1,100 | $9.00K |